about
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adultsRoads Less Traveled: Sexual Dimorphism and Mast Cell Contributions to Migraine PathologyFormalized consensus: clinical practice recommendations for the management of the migraine in African adult patientsAntidepressant use and risk for preeclampsia.Transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutamatergic [corrected] - and insulin-mediated neuronal processes.Are migraine and tension-type headache diagnostic types or points on a severity continuum? An exploration of the latent taxometric structure of headache.Effect of amitriptyline on tetrodotoxin-resistant Nav1.9 currents in nociceptive trigeminal neurons.Migraine and depression: bidirectional co-morbidities?Panic disorder and migraine: comorbidity, mechanisms, and clinical implications.Drug repositioning: playing dirty to kill pain.Persistent orthostatic headache without intracranial hypotension: which treatment?Choosing the safest acute therapy during chronic migraine prophylactic treatment: pharmacokinetic and pharmacodynamic considerations.Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.Antidepressant use among survivors of childhood, adolescent and young adult cancer: a report of the Childhood, Adolescent and Young Adult Cancer Survivor (CAYACS) Research Program.Blockade of Nav1.8 currents in nociceptive trigeminal neurons contributes to anti-trigeminovascular nociceptive effect of amitriptyline.Amitriptyline and aerobic exercise or amitriptyline alone in the treatment of chronic migraine: a randomized comparative study.
P2860
Q24188076-23A3A811-040D-49D2-B06E-43DE2A6F74DAQ26752538-842492DD-C20C-49CB-87C5-64E7338ED486Q28066203-740FE49B-2A2D-4BF0-948D-FEA60F666FD5Q34158083-448AF1FB-0DF5-4C07-A5DD-C33E5836959AQ34571919-9317E774-9AB6-4FA4-A148-A74B020A244DQ35914485-45E1C90B-7B2E-4DE4-B079-6BF0041B0AE7Q36953269-091820FF-4D4B-4A60-91CB-F6D422F1CAFDQ38014292-034C487B-BB4B-478A-BDF0-88E0BE53E8C8Q38070731-2804ACAE-3A2E-41CF-A749-8CB8E0ED4194Q38170322-5184A560-6ED8-4A6A-BA22-7C67153B8452Q38504750-CC264C76-F2A9-4E20-A980-C924FA07020DQ38734042-6F9BDF04-2143-433B-985C-8ABD4C027557Q38831882-DA31C3D4-C546-4C27-AC21-0D89B87B816BQ43795259-D92325AD-3C57-43D1-82FD-CE62ADD5C62DQ44135636-C20C6008-9C71-4EA2-A6A6-4308ED34E847Q48173046-50878592-B1E4-42F2-A630-E61E372D849E
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The use of antidepressants for headache prophylaxis.
@en
The use of antidepressants for headache prophylaxis.
@nl
type
label
The use of antidepressants for headache prophylaxis.
@en
The use of antidepressants for headache prophylaxis.
@nl
prefLabel
The use of antidepressants for headache prophylaxis.
@en
The use of antidepressants for headache prophylaxis.
@nl
P2860
P1476
The use of antidepressants for headache prophylaxis.
@en
P2093
A Brooke Walters
Morris Maizels
P2860
P304
P356
10.1111/J.1755-5949.2010.00170.X
P577
2010-07-07T00:00:00Z